BE THE NEW

(Senior) Clinical Pharmacology Scientist

in a biotech company focused on the discovery, design and development of innovative peptide-based medicines


Currently, we are looking for one or more Clinical Pharmacology Scientists, who has a track record in clinical pharmacology, clinical experimental research or trial management with a strong scientific capability. If this sounds like you, and you are ready to take on a broad area of responsibilities with an independent attitude, you are a match for us.​

The Clinical Pharmacology function is part of the Medical & Science department which currently consists of 6 Medical Experts and 5 Clinical Pharmacologists with diverse backgrounds. Your task is to design, plan and conduct early phase clinical trials to improve the understanding of a compound, including clinical pharmacology aspects and integration of experimental medical research in biomarkers and relevant methods to measure disease change. You will refer to the Head of Medical & Science. This area of Zealand Pharma is undergoing a fast development with many near future opportunities depending on your competencies and engagement.

Responsibilities

In the position as Clinical Pharmacology Scientist you will be responsible for contributing to the clinical and regulatory development plans and strategies for specific projects. You collaborate with the project teams to implement and execute the clinical plans according to applicable guidelines to ultimately support marketing authorizations. You will lead the cross-functional trial team together with a trial manager. You are responsible for the scientific content and strategic fit of the trial, and for ensuring the overall implementation of the trial plans from ideation to reporting. Zealand Pharma is working with a fully outsourced operating model utilizing CROs for the operational trial implementation. Your ability to lead and oversee complex operations is important.

Candidate profile


Bonding to innovate ​

Our employees are fundamental to our success, and we continue to be able to attract and retain people with vast experience and talent. We have a unique culture, characterized by excellent teamwork and strong engagement across the organization.​

Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other.​

We bond as a result of our entrepreneurial culture where our people are encouraged to pursue their ideas and turn them into reality. We are curious about each other’s knowledge and expertise. ​

We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Zealand Pharma is a place where everyone is heard and contributes to the success, we all want to experience.​

The Zealand Pharma DNA builds on four values: (1) We are bold, (2) We empower people, (3) We work as one team, and (4) We can be trusted.​

Let’s bond and be bold ​

We offer a combined compensation package which includes a base salary, pension, bonus, and a possibility to join our employee share program. We care about our employees’ well-being and offer health insurance, use of massage, fitness, and a range of social clubs and activities

To find out more about working at Zealand, visit https://www.zealandpharma.com/careers/zealand-as-a-workplace/

Interested? Please apply no later than September 15th 2024, or as soon as possible. The applications will be reviewed as they come in.

For further information, please contact Thue Johansen, VP Head of Medical & Science, tjo@zealandpharma.com, +45 5060 3889.

About Zealand Pharma A/S

Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company on a mission to change lives with next generation peptide medicines. In our effort to reach our goals bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other. This has led to more than 10 drug candidates invented by Zealand having advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on specialty gastrointestinal and metabolic diseases. Additionally, the portfolio includes clinical license collaboration with Boehringer Ingelheim and pre-clinical license collaboration with Alexion Pharmaceuticals. Zealand is based in Copenhagen (Søborg), Denmark. For further information about the Company's business and activities, please visit www.zealandpharma.com or bond with us through LinkedIn.




Stillingen er ikke aktiv og kan ikke søges